United States

People: Genomic Health Inc (GHDX.OQ)

GHDX.OQ on NASDAQ Stock Exchange Global Select Market

4:00pm EDT
Change (% chg)

$-0.81 (-1.23%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Shak, Steven 

Dr. Steven Shak, M.D., serves as Chief scientific officer of the Company. From July 1996 to October 2000, Dr. Shak served in various roles in Medical Affairs at Genentech, most recently as Senior Director and Staff Clinical Scientist. From November 1989 to July 1996, Dr. Shak served as a Director of Discovery Research at Genentech, where he was responsible for Pulmonary Research, Immunology, and Pathology. Prior to joining Genentech, Dr. Shak was an Assistant Professor of Medicine and Pharmacology at the New York University School of Medicine. Dr. Shak holds a B.A. in Chemistry from Amherst College and an M.D. from the New York University School of Medicine, and completed his post-doctoral training at the University of California, San Francisco.

Basic Compensation

Total Annual Compensation, USD 690,940
Restricted Stock Awards, USD 186,314
Long-Term Incentive Plans, USD --
All Other, USD 540,949
Fiscal Year Total, USD 1,418,200

Options Compensation

  Quantity Market Value
Exercisable 17,337 157,940.00
Unexercisable 102,011 473,820.00
Exercised 30,000 210,870.00
Name Fiscal Year Total

Kimberly Popovits


Gordon Cole


Steven Shak


Phillip Febbo


Laura Kammeyer


Frederic Pla

As Of  30 Dec 2017